Description: Further DetailsTitle: Horizons in Cancer Research. Volume 73Condition: NewSubtitle: Volume 73ISBN-10: 1536162736EAN: 9781536162738ISBN: 9781536162738Publisher: Nova Science Publishers IncFormat: HardbackRelease Date: 10/15/2019Language: EnglishCountry/Region of Manufacture: USItem Weight: 444gContributor: Hiroto S. Watanabe (Edited by)Author: Hiroto S. WatanabeGenre: MedicineDescription: In Horizons in Cancer Research. Volume 73, after the identification of some small subgroups with a strong biological-molecular identity, the current evidence regarding the prognostic factors of patients with non-eradicable metastatic disease are examined. The goal is to discuss disease subgroups, which may sometimes provide conditions for decisions that are less compliant with current clinical practice and help define new stratification criteria for patients enrolled in prospective studies. Following this, the authors summarize the current knowledge on breast cancer with an introduction on the traditional markers used in the diagnosis of this disease, followed by an account of the emerging markers. Next, the underlying mechanisms of DNA replication, damage and repair are discussed. Further, RAD51 is proposed as a potential means of managing chemoresistant cancers. Certain drugs and strategies can sensitize chemotherapy via impacting on RAD51, which can be developed as chemotherapy modulators. The authors also discuss multiple myeloma, an incurable malignant tumor of plasma cells of the bone marrow, which is the most common primary neoplasm arising in bone. It causes approximately 1% of cancer-related deaths and is the 2nd most common hematological malignancy in the western world. Later, this collection discusses the prevalence and types of infectious complications that patients with multiple myeloma face, as well as present and emerging therapeutic approaches. The concluding study indicates proteins that have a promising future as new anticancer drugs, in conjunction with the in vitro and/or in vivo effects of these bioactive proteins derived from plants.Release Year: 2019 Missing Information?Please contact us if any details are missing and where possible we will add the information to our listing.
Price: 276.43 USD
Location: GU14 0GT
End Time: 2025-01-25T19:15:28.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
Restocking Fee: No
Return shipping will be paid by: Buyer
All returns accepted: Returns Accepted
Item must be returned within: 30 Days
Refund will be given as: Money back or replacement (buyer's choice)
Book Title: Horizons in Cancer Research. Volume 73
Title: Horizons in Cancer Research. Volume 73
Subtitle: Volume 73
ISBN-10: 1536162736
EAN: 9781536162738
ISBN: 9781536162738
Release Date: 10/15/2019
Release Year: 2019
Country/Region of Manufacture: US
Contributor: Hiroto S. Watanabe (Edited by)
Genre: Medicine
Number of Pages: 235 Pages
Language: English
Publication Name: Horizons in Cancer Research. Volume 73
Publisher: NOVA Science Publishers, Incorporated
Publication Year: 2019
Subject: Oncology
Type: Textbook
Item Weight: 15.7 Oz
Item Length: 9 in
Author: Hiroto S. Watanabe
Subject Area: Medical
Series: Horizons in Cancer Research Ser.
Item Width: 6 in
Format: Hardcover